Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
64.01
-1.55 (-2.36%)
Jan 29, 2026, 9:53 AM EST - Market open
Bio-Techne Employees
Bio-Techne had 3,100 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
3,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$392,494
Profits / Employee
$25,145
Market Cap
9.97B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3,100 | 0 | - |
| Jun 30, 2024 | 3,100 | 50 | 1.64% |
| Jun 30, 2023 | 3,050 | 50 | 1.67% |
| Jun 30, 2022 | 3,000 | 400 | 15.38% |
| Jun 30, 2021 | 2,600 | 300 | 13.04% |
| Jun 30, 2020 | 2,300 | 50 | 2.22% |
| Jun 30, 2019 | 2,250 | 250 | 12.50% |
| Jun 30, 2018 | 2,000 | 200 | 11.11% |
| Jun 30, 2017 | 1,800 | 240 | 15.38% |
| Jun 30, 2016 | 1,560 | 204 | 15.04% |
| Jun 30, 2015 | 1,356 | 335 | 32.81% |
| Jun 30, 2014 | 1,021 | 167 | 19.56% |
| Jun 30, 2013 | 854 | 7 | 0.83% |
| Jun 30, 2012 | 847 | 13 | 1.56% |
| Jun 30, 2011 | 834 | 97 | 13.16% |
| Jun 30, 2010 | 737 | -9 | -1.21% |
| Jun 30, 2009 | 746 | 27 | 3.76% |
| Jun 30, 2008 | 719 | 38 | 5.58% |
| Jun 30, 2007 | 681 | 44 | 6.91% |
| Jun 30, 2006 | 637 | 28 | 4.60% |
| Jun 30, 2005 | 609 | 12 | 2.01% |
| Jun 30, 2004 | 597 | 11 | 1.88% |
| Jun 30, 2003 | 586 | 16 | 2.81% |
| Jun 30, 2002 | 570 | 9 | 1.60% |
| Jun 30, 2001 | 561 | 64 | 12.88% |
| Jun 30, 2000 | 497 | 26 | 5.52% |
| Jun 30, 1999 | 471 | 60 | 14.60% |
| Jun 30, 1998 | 411 | 46 | 12.60% |
| Jun 30, 1997 | 365 | -7 | -1.88% |
| Jun 30, 1996 | 372 | 28 | 8.14% |
| Jun 30, 1995 | 344 | 67 | 24.19% |
| Jun 30, 1994 | 277 | 71 | 34.47% |
| Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,040 |
| Jazz Pharmaceuticals | 2,800 |
| Exelixis | 1,147 |
| Ionis Pharmaceuticals | 1,069 |
| Axsome Therapeutics | 816 |
| Arrowhead Pharmaceuticals | 711 |
| Madrigal Pharmaceuticals | 528 |
| Avidity Biosciences | 391 |
TECH News
- 20 hours ago - Madison Mid Cap Fund Q4 2025 Portfolio Activity - Seeking Alpha
- 1 day ago - Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers - PRNewsWire
- 9 days ago - Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results - PRNewsWire
- 15 days ago - Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference - PRNewsWire
- 7 weeks ago - Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis - PRNewsWire
- 7 weeks ago - Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript - Seeking Alpha
- 2 months ago - Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha